As TDO2 has also been shown to promote tumor growth in some cancers, it is reasonable to speculate that TDO2 and IDO2 may act as compensatory pathways to continue KYN production and influence tumor immunity when IDO1 is inhibited. This evidence concerns the gene IDO2 and neoplasm.